Englewood Lab, Inc. (KOSDAQ:950140)

Market Cap	225.50B +44.4%
Revenue (ttm)	216.79B +19.0%
Net Income	24.81B +26.4%
EPS	1,252.00 +27.5%
Shares Out	19.87M
PE Ratio	9.07
Forward PE	n/a
Dividend	100.00 (0.89%)
Ex-Dividend Date	Dec 29, 2025

Volume	47,167
Average Volume	101,459
Open	11,500
Previous Close	11,520
Day's Range	11,230 - 11,650
52-Week Range	8,040 - 16,910
Beta	0.46
RSI	39.68
Earnings Date	May 8, 2026

About Englewood Lab

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2004
• Country: United States
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950140

Financial Performance

In 2025, Englewood Lab's revenue was 216.79 billion, an increase of 18.97% compared to the previous year's 182.22 billion. Earnings were 24.81 billion, an increase of 26.42%.